Viracept (nelfinavir) / ViiV Healthcare, Roche 
Welcome,         Profile    Billing    Logout  

11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Viracept (nelfinavir) / ViiV Healthcare, Roche
2004-000441-38: Large, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study)

 
3/4
2
Europe
NA, NA, INVIRASE*270 CPS 200 MG, NORVIR*336 CPS MOLLI 100 MG, CRIXIVAN*180 CPS 400 MG, VIRACEPT*270 CPR 250 MG, FORTOVASE*180 CPS 200 MG, AGENERASE*240 CPS 150 MG, KALETRA*180 CPS BLISTER, VIRAMUNE*60 CPR 200 MG, SUSTIVA*90 CPS 200 MG, RETROVIR* 28 CPR 300 MG, VIDEX 400*30 CPS 400 MG, HIVID 0,750*100 CPR 0,750 MG, ZERIT 40*56 CPS 40 MG, EPIVIR*60 CPR 150 MG, COMBIVIR*60CPR BL 150/300MG, ZIAGEN*60 CPR RIV. 300 MG, TRIZIVIR*60 CPR RIV. BLISTER, VIREAD*30 CPR 245 MG, FUZEON*90MG/ML 60FL+60FL+60S
National Institute of Allergy and Infectious Diseases, National Institutes of Health, COMMUNITY PROGRAMS FOR CLINICAL RESEARCH ON AIDS
HIV infection
 
 
NELCER, NCT03256916: Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix

Recruiting
3
348
RoW
Nelfinavir, Cisplatin, Pelvic EBRT and Brachytherapy, Radiation Therapy
Tata Memorial Hospital
Carcinoma Cervix,Stage III
09/25
09/25
ARTISTRY-1, NCT05502341: Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

Recruiting
2/3
671
Europe, Canada, Japan, US, RoW
Bictegravir, GS-9883, Lenacapavir, GS-6207, BIC/LEN FDC, Stable Baseline Regimen
Gilead Sciences
HIV-1-infection
01/26
11/28
NCT04471662: Nelfinavir and Favipiravir Combination in Newly Diagnosed COVID19 Egyptian Patients

Not yet recruiting
2
50
NA
Nelfinavir/Favipiravir, Avigan, Active comparator, Oxygen via ventilators
Tanta University
COVID-19
11/20
12/20
NCT02207439: Phase II Trial of Nelfinavir With Concurrent Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck

Completed
2
18
US
Nelfinavir (Viracept®) 1250 mg, Nelfinavir Lead-In, Chemoradiation
Abramson Cancer Center at Penn Medicine
Head and Neck Squamous Cell Carcinoma
05/21
05/22
2006-001031-22: The Potentiation of Efficacy of Radiotherapy in Non-Small-Cell Lung Cancer (NSCLC) by Inhibition of Akt Activation

 
1/2
64
Europe
Viracept, Viracept
Institute of Cancer Research
Non-small-cell lung cancer
 
 
COAST, NCT05036226: Therapy in Advanced Solid Tumors and Prostate Cancer

Recruiting
1/2
76
US
Hydroxychloroquine, Metformin, Sirolimus, Hydroxychloroquine, Metformin, Sirolimus, Dasatanib, Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir, Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir, Dasatinib
Medical University of South Carolina
Prostate Cancer Recurrent, Solid Tumor, Adult
10/24
10/25
NCT00436735: Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors

Active, not recruiting
1
45
US
midazolam hydrochloride, nelfinavir mesylate, gene expression analysis, polymerase chain reaction, protein expression analysis, immunoenzyme technique, immunologic technique, laboratory biomarker analysis, mass spectrometry
National Cancer Institute (NCI)
Colorectal Cancer, Gastrointestinal Carcinoid Tumor, Head and Neck Cancer, Islet Cell Tumor, Lung Cancer, Metastatic Cancer, Neuroendocrine Carcinoma of the Skin, Ovarian Cancer, Pheochromocytoma, Sarcoma, Unspecified Adult Solid Tumor, Protocol Specific
 
 
NCT03829020: Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma

Completed
1
9
US
Bortezomib, [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid, LDP 341, MLN341, PS-341, PS341, Velcade, Metformin Hydrochloride, APO-Metformin, Cidophage, Dimefor, Glifage, Glucoformin, Glucophage, Glucophage ER, Metformin HCl, Riomet, Siofor, Nelfinavir Mesylate, AG1343, Viracept
Mayo Clinic, National Cancer Institute (NCI)
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
09/22
11/23
NCT04169763: Nelfinavir, Cisplatin, and External Beam Radiation Therapy for the Treatment of Locally Advanced Vulvar Cancer That Cannot Be Removed by Surgery

Recruiting
1
18
US
Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone''s Chloride, Peyrone''s Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam Radiation, External Beam Radiotherapy, External Beam RT, external radiation, External Radiation Therapy, external-beam radiation, Radiation, External Beam, Nelfinavir
M.D. Anderson Cancer Center, National Cancer Institute (NCI)
Stage II Vulvar Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IIIA Vulvar Cancer AJCC v8, Stage IIIB Vulvar Cancer AJCC v8, Stage IIIC Vulvar Cancer AJCC v8, Stage IVA Vulvar Cancer AJCC v8
12/26
12/26
NCT00476606: A Prospective Cohort of Children With HIV Infection

Active, not recruiting
N/A
500
RoW
Zidovudine, Stavudine, Didanosine, Lamivudine, Nevirapine, Efavirenz, LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir
The HIV Netherlands Australia Thailand Research Collaboration, Khon Kaen University
HIV Infections
06/24
06/24

Download Options